Search Medical Condition
Please enter condition
Please choose location
Clear Trial Filters
 

Obesity Clinical Trials

A listing of Obesity medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (17) clinical trials

Dr. Samuel Klein will look at why some obese persons are resistant to developing obesity related metabolic diseases (like diabetes and high cholesterol) while other obese persons do develop these conditions. This study lasts 18 weeks. There will be a medical screening visit, MRI/DXA scans, metabolism studies, biopsies, and a ...

Phase

A study to evaluate the effect of long-term treatment with Belviq® (Lorcaserin HCI) on the incidence of major adverse cardiovascular events and conversion to Type 2 Diabetes Mellitus in obese and overweight subjects with cardiovascular disease or multiple cardiovascular risk factors. Half of the patients will be randomly assigned to ...

Phase

Rajavithi Health Promotion Project (Population Base Cohort)

Metabolic Syndrome (hypertension, diabetes mellitus, obesity, cerebrovascular-cardiovascular disease) In Community Survey was performed in central Bangkok. Prospective Cohort and intensive educated intervention (health promotion program in specific high risk groups) were performed. The aim of the study is to identify high risk patients who can develop serious complications from metabolic ...

Phase

Detemir Energy Expenditure Study

This is a study designed to compare the effects of 2 long-acting insulins, detemir and insulatard, on energy expenditure,weight, fat composition, gut hormone profiles, glycaemic control and fat and muscle gene expression over a 6 month period.

Phase

Kagoshima Collaborate Trial in Metabolic Syndrome (KACT Study)

The primary endpoints are: - blood pressure control - Adiponectin and plasma type1 plasminogen active inhibitor The secondary endpoints are - HOMA-IR - HbA1c - TNF-α - IL-6 - Plasma B-type natriuretic peptide - LVMI - E/A ratio - Tei-index - Apo-J

Phase

Trial Comparing Metformin Versus Placebo in Non Alcoholic Steatohepatitis (NASH) Patients Receiving Bariatric Surgery for Obesity

In patients receiving bariatric surgery, a preoperative liver biopsy will confirm the presence of NASH. Those patients with NASH (histologically defined according the Brunt's criteria) will be randomized to receive metformin (2 times 850 mg orally daily) or placebo for a time period of 1 year. A control liver biopsy ...

Phase

Comparison of Two Approaches to Weight Loss Follow-Up Study

***PLEASE NOTE: Only those who participated in the original study of low carbohydrate and low fat diets are eligable for enrollment in this follow-up study***

Phase

Mechanisms of Weight Loss With SGLT2 Inhibition

The purpose of this study is to investigate the effect of canagliflozin, a medication approved by the FDA for the treatment of type 2 diabetes, on body weight and metabolism in people with type 2 diabetes who are overweight or obese. Canagliflozin lowers glucose levels in the blood by making ...

Phase

St. Vincent's Screening To Prevent Heart Failure Study

A large proportion of the population has substantial left ventricular dysfunction (LVD) and do not have symptoms (Stage B heart failure). For many of these patients, if identified and treated appropriately, it is possible to prevent the subsequent development of heart failure (HF). Although the current gold standard for detection ...

Phase

Effect of Laparoscopic Sleeve Gastrectomy in the Morbidly Obese Kidney Transplant Candidate

The remaining factor in determining the effectiveness of bariatric surgery in the transplant population will be to study the effect on the pharmacokinetics of immunosuppressive medication, height, weight, BMI, abdominal circumference, blood pressure, Hba1c , average daily insulin requirements, lipid profile, TSH, 24h urine creatinine clearance and the SF-36 Quality ...

Phase